Table 2.

Flow-mediated dilatation as measured by ultrasound. N = 35, mean SD. Treatments with different superscripts are different at $P<.05$.

	Baseline	GSE	GSE/quercetin	Control
Precompression cm−2	44.3 ± 6.3	45.1 ± 6.4	45.9 ± 7.2	45.5 ± 7.3
Postcompression	46.2 ± 5.8	47.4 ± 6.5	47.6 ± 7.5	47.3 ± 7.3
	(n = 30)	(n = 35)	(n = 32)	(n = 36)
Change	1.91,2 ± 1.3	2.31 ± 1.4	1.72 ± 1.0	1.82 ± 1.3
	(4.3%)	(5.1%)	(3.7%)	(4.0%)
Pre-GTN	44.8 ± 7.1	45.8 ± 7.1	46.9 ± 7.5	46.2 ± 7.1
Post-GTN	52.1 ± 6.8	52.7 ± 6.9	52.9 ± 7.3	52.8 ± 7.0
	(n = 38)	(n = 30)	(n = 29)	(n = 31)
Change	7.31 ± 2.4	6.91,2 ± 2.3	6.02 ± 3.0	6.51,2 ± 1.8
	(16.3%)	(15.1%)	(12.8%)	(14.1%)